105个医保目录新药落地全国1万多家定点医药机构

Core Insights - The National Healthcare Security Administration (NHSA) announced that as of January 11, 2026, 105 newly negotiated drugs will be available in 11,129 designated medical institutions across the country, including 6,537 medical institutions and 4,592 retail pharmacies [1] - Additionally, 19 innovative commercial insurance drugs will be available in 965 designated medical institutions, comprising 449 medical institutions and 516 retail pharmacies [1] - The NHSA has organized relevant companies to submit lists of institutions equipped with the newly negotiated drugs and innovative commercial insurance drugs for the 2025 version of the medical insurance catalog [1] Summary by Category Negotiated Drugs - Out of the 105 newly negotiated drugs, 88 have available institution information [1] - The NHSA will focus on monitoring and guiding companies to ensure the availability of drugs that have not yet been equipped in designated medical institutions, thereby safeguarding the medication rights of insured individuals [1] Innovative Commercial Insurance Drugs - Among the 19 innovative commercial insurance drugs, 16 have available institution information [1] - The data regarding the equipped institutions for both negotiated and innovative drugs is published on the NHSA's official website and the National Medical Insurance Service Platform App for insured individuals to access [1]